Comparison of clinical characteristics and magnetic resonance imaging of salivary glands with magnetic resonance sialography in sjögren's syndrome

Andre, Raphaël; Becker, Minerva; Lombardi, Tommaso; Buchholzer, Samanta; Marchal, Francis; Seebach, Jorg Dieter

doi:10.1002/lary.28742

Scientific article

English

Comparison of clinical characteristics and magnetic resonance imaging of salivary glands with magnetic resonance sialography in sjögren's syndrome

ContributorsAndre, Raphaël; Becker, Minerva; Lombardi, Tommaso; Buchholzer, Samanta; Marchal, Francis; Seebach, Jorg Dieter

Published inLaryngoscope

Publication date2020

Abstract

To compare the results of magnetic resonance imaging with magnetic resonance sialography (MRSIAL) and the clinical and laboratory characteristics in a well-characterized cohort of patients with primary or secondary Sjögren's syndrome (SS) meeting the American-European Consensus Group criteria.

Keywords

Sjögren's syndrome
Magnetic resonance imaging
Magnetic resonance sialography
Sicca syndrome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Citation (ISO format)

ANDRE, Raphaël et al. Comparison of clinical characteristics and magnetic resonance imaging of salivary glands with magnetic resonance sialography in sjögren’s syndrome. In: Laryngoscope, 2020. doi: 10.1002/lary.28742

Article (Published version)

Identifiers

PID : unige:136310
DOI : 10.1002/lary.28742
PMID : 32413167

Journal ISSN0023-852X

348views

4downloads

Creation28/05/2020 16:16:00

First validation28/05/2020 16:16:00

Update15/03/2023 22:00:16

Status update15/03/2023 22:00:16

Last indexation31/10/2024 18:45:21

Archive ouverte UNIGE

Comparison of clinical characteristics and magnetic resonance imaging of salivary glands with magnetic resonance sialography in sjögren's syndrome

To compare the results of magnetic resonance imaging with magnetic resonance sialography (MRSIAL) and the clinical and laboratory characteristics in a well-characterized cohort of patients with primary or secondary Sjögren's syndrome (SS) meeting the American-European Consensus Group criteria.

Technical informations